Neurocrine Biosciences (NasdaqGS:NBIX) FY Conference September 17, 2025 12:40 PM ET Company ParticipantsKyle Gano - CEOTodd Tushla - VP of Investor RelationsSanjay Keswani - Chief Medical OfficerConference Call ParticipantsPhil Nadeau - Managing Director and Senior Research AnalystPhil NadeauGood afternoon and welcome to TD Cowen's Neuroscience Summit. I'm Phil Nadeau, one of the biotech analysts here at TD Cowen, and it's my pleasure to moderate a fireside chat with Neurocrine Biosciences. We have with us ...